FATTIZZO, BRUNO
FATTIZZO, BRUNO
Dipartimento di Oncologia ed Emato-Oncologia
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience
2026 B. Fattizzo, E. Sambruna, Y. Miyakawa, M. Michel, C. Visco, M. Fillitz, G. Kannourakis, M.B. Greve, M. Kleemiss, J. Cid, A. Patriarca, L. Pavan, A. Dizdari, N. Maschio, A. Sau, C. Bitetti, R.M. Colombo, L. Curreli, D. Lame, U. Markovic, F. Pappagallo, G.L. Pedone, D. Rapezzi, V. Sammartano, N. Tumedei, A.G. Solimando, J. Marit, L. Fianchi, J. Khwaja, A. De Vivo, F. Lanza, F. Vianello, E.N. Oliva, C. Broome, F. Passamonti, U. Jaeger, B. Jilma, G. Moulis, W. Barcellini
Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia
2026 B. Fattizzo, A. Zaninoni, G.L. Pedone, M. Bortolotti, F. Passamonti, W. Barcellini
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma
2026 S. Perrone, R. Tomasello, S. Raso, O. Annibali, M. Tafuri, M. Mattana, T. Soriano, D. Fanciullo, G.M. Assanto, G.L. Pedone, E. Baldacci, E. Santacroce, U. Markovic, G. Giuffrida, M.G. Ingrascì, M. Biglietto, C. Cammarata, M. Totaro, S. Ligia, B. Fattizzo, C. Santoro, S. Siragusa, M. Napolitano
Thrombosis in paroxysmal nocturnal hemoglobinuria in the complement inhibitor era: mechanisms, risk stratification, and clinical management
2026 B. Fattizzo, C.Q. Schmidt
Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab
2026 A. Sau, D. Onofrillo, A.C. Russo, G. Di Prinzio, A.M. Quaglietta, M. Di Ianni, B. Fattizzo
Predicting the differential diagnosis of inherited versus acquired bone marrow failure syndromes: Development of simple clinical scoring systems
2026 M. Bortolotti, B. Fattizzo, S. Stella, J. Jiang, F. Versino, C. Engelbrecht, R. Trikha, J. Large, S. Gandhi, K. Snape, D. Consonni, F. Passamonti, W. Barcellini, A.G. Kulasekararaj
Mixed Type Autoimmune Hemolytic Anemia: Clinical Severity and Treatment Patterns in a Large Observational Study
2026 F. Versino, U. Markovic, G.L. Pedone, S. Pergolizzi, F. Passamonti, W. Barcellini, A. Romano, B. Fattizzo
Sutimlimab vs B-Cell-Targeted Therapy in Cold Agglutinin Disease: Which Is the Optimal Approach?
2026 B. Fattizzo, Y. Miyakawa, C. Broome
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study
2026 A.P. Iori, A. De Vivo, E. Di Bona, G. Caocci, F. Fioritoni, F. Ciceri, E. Beggiato, D. Rapezzi, A. Amendola, A. Figuera, C. Selleri, F. Longu, B. Fattizzo, A. Tucci, A. Cignetti, V. Amico, S. Sica, E. Metafuni, S. Raso, T.A. Urbano, L. Marano, N. Di Renzo, P. Spedini, A. Rambaldi, F. Lanza, C. Clissa, C. Danesin, M.B. Greve, S. Cabibbo, A. Ori, F. Cassanelli, F. Sottana, B. Campolo, G. Gasparri, F. Carini, W. Barcellini
Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy
2026 W. Barcellini, B. Fattizzo
Clinical Heterogeneity and Outcome of acquired PRCA: a Multicenter European Study
2026 F. Versino, M. Michel, J. Vidler, S. Payán-Pernía, R. Trikha, S.A. Gandhi, S. Gogoi, M. Wimalachandra, O. Racchi, M.T. Lupo-Stanghellini, S. Giammarco, M. Arguello Marina, M. Memoli, A. Glenthøj, G. Merati, Y.W. Wickramasinghe, A. Chitharanjan, M. Hemmer, M. Napolitano, M. Jimenez-Jambrina, F. Brioschi, A. Palma-Vallelano, T.J. Gonzalez-Lopez, C. Clissa, M. Bortolotti, G.L. Pedone, G.A. Croci, F. Passamonti, W. Barcellini, A.G. Kulasekararaj, B. Fattizzo
Thrombophilia screening in patients with autoimmune hemolytic anemia: a single-center analysis
2026 B. Fattizzo, M. Abbatista, N. Cecchi, C. Novembrino, M. Boscolo-Anzoletti, G.L. Pedone, M. Bortolotti, A. Artoni, J.A. Giannotta, F. Peyvandi, F. Passamonti, W. Barcellini, M. Capecchi
Autoimmune Complications of Lymphoproliferative Diseases
2025 W. Barcellini, B. Fattizzo
Exploring patients’ experiences with wAIHA and the content validity of the FACIT-fatigue: a qualitative interview study
2025 A. Shukla, O. Cooper, K. Jones, Q.A. Hill, K. Mccrae, B. Fattizzo, M. Kostikas, M. Krol, S. Bascle, S. Bozzi, A. Daak, J. Maher
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience
2025 B. Fattizzo, G.L. Pedone, E. Metafuni, E. Beggiato, V. Giai, E. Natalie Oliva, A. Ricchiuti, M. Bortolotti, S. Raso, D. Carlino, M. Memoli, S. Vecchi, J. Vidler, S. Gogoi, S. Goel, A. Corby, R. Trikha, S. Balakrishnan, F. Passamonti, A. Paola Iori, S. Sica, S. Gandhi, W. Barcellini, A. Kulasekararaj
Not-so-rare defects of RBC lipidic composition: four new cases of flippase deficiency due to ATP11C mutations
2025 E. Fermo, E. Trombetta, A.P. Marcello, C. Vercellati, G.M. Ferrari, A. Zaninoni, V. Brancaleoni, E. Di Pierro, S. Beneventi, M. Tornese, B. Fattizzo, T. Casini, P. Corti, P. Bianchi
Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice
2025 B. Fattizzo, F. Versino, W. Barcellini
Management of autoimmune hemolytic anemia
2025 W. Barcellini, B. Fattizzo
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
2025 E. Crisà, D. Cilloni, M. Riva, E. Balleari, D. Barraco, B. Manghisi, L. Borin, M. Calmasini, A. Calvisi, I. Capodanno, M.G. Della Porta, E. Diral, B. Fattizzo, S. Fenu, S. Paolini, C. Finelli, C. Fozza, C. Frairia, V. Giai, M. Turrini, M.A. Isoni, F. Itri, L. Maurillo, A. Molteni, G.A. Palumbo, A.M. Pelizzari, F. Pilo, A. Poloni, C. Bosi, G. Sanpaolo, R. Sancetta, C. Amato, V. Santini, M.T. Voso, S. Salek, T. Ionova, A. Nosari, E.N. Oliva
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing
2025 B. Fattizzo, M.C. Da Via, F. Lazzaroni, A. Marchetti, A. Marella, A. Maeda, A.G. Solimando, L. Pettine, F. Passamonti, N. Bolli, W. Barcellini